¼¼°èÀÇ ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ® ½ÃÀå
Self-Expanding Stents
»óǰÄÚµå : 1784112
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 226 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,222,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,666,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ® ¼¼°è ½ÃÀåÀº 2030³â±îÁö 45¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 38¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ® ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 3.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 45¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ °æµ¿¸Æ ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ®´Â CAGR 2.9%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 21¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À§Àå ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ® ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 2.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 9¾ï 8,910¸¸ ´Þ·¯, Áß±¹Àº CAGR 3.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ® ½ÃÀåÀº 2024³â¿¡ 9¾ï 8,910¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 7¾ï 2,850¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 3.0%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 2.7%¿Í 2.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 2.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ® ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

½ÉÇ÷°ü ¹× ¸»ÃÊ ½Ã¼ú¿¡¼­ ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ®ÀÇ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ®´Â ÇùÂø ¶Ç´Â ¸·Èù µ¿¸Æ ȯÀÚÀÇ Ç÷·ù¸¦ °³¼±ÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ ÁßÀçÀû ½ÉÀ庴ÇÐ ¹× Ç÷°ü ½Ã¼úÀÇ ÇÙ½ÉÀÌ µÇ°í ÀÖ½À´Ï´Ù. dz¼± È®ÀåÇü ½ºÅÙÆ®´Â ½ºÅÙÆ®¸¦ ¿­ ¶§ ¿Ü¾ÐÀÌ ÇÊ¿äÇÏÁö¸¸, ÀÚ°¡ÆØÃ¢Çü ½ºÅÙÆ®´Â ½ºÅÙÆ®¸¦ Àü°³ÇÒ ¶§ ÀÚµ¿À¸·Î È®ÀåµÇ±â ¶§¹®¿¡ Ç÷°üÀÇ ¿òÁ÷ÀÓ¿¡ À¯¿¬ÇÏ°Ô ´ëÀÀÇÒ ¼ö ÀÖ½À´Ï´Ù. °ü»óµ¿¸ÆÁúȯ(CAD) ¹× ¸»Ãʵ¿¸ÆÁúȯ(PAD)À» Æ÷ÇÔÇÑ ½ÉÇ÷°ü°è Áúȯ(CVD)ÀÇ À¯º´·ü Áõ°¡´Â ÷´Ü ½ºÅÙÆ® ±â¼úÀÇ Çʿ伺À» ´õ¿í ºÎÃß±â°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȸº¹ ½Ã°£ ´ÜÃà, ÇÕº´Áõ À§Çè °¨¼Ò, Àå±âÀûÀΠȯÀÚ °á°ú °³¼±À¸·Î À̾îÁö´Â ÃÖ¼Òħ½À ¼ö¼úÀÇ Áõ°¡´Â ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ®¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ®ÀÇ È¿°ú¸¦ ³ôÀÌ´Â ±â¼ú Çõ½ÅÀº ¹«¾ùÀΰ¡?

»ýü Àç·á¿Í ¾à¹° ¿ëÃ⼺ ÄÚÆÃÀÇ ¹ßÀüÀº ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ®ÀÇ ¼º´É°ú ¾ÈÀü¼ºÀ» Å©°Ô Çâ»ó½ÃÄ×½À´Ï´Ù. ´ÏƼ³î(´ÏÄÌ-ƼŸ´½ ÇÕ±Ý) ½ºÅÙÆ®´Â ÃÊź¼ºÀÌ°í º¯ÇüÀÌ Àû±â ¶§¹®¿¡ ¼±È£µÇ´Â ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù. Ç×Áõ½ÄÁ¦¸¦ ¹æÃâÇÏ´Â ¾à¹° ¿ëÃâ ½ºÅÙÆ®(DES)´Â ÀçÇùÂø(µ¿¸Æ ÀçÇùÂø)ÀÇ À§ÇèÀ» °¨¼Ò½ÃÄÑ Àå±âÀûÀÎ °³ÅëÀ» º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ, µ¿¸ÆÀÌ Ä¡À¯µÈ ÈÄ Ã¼³»¿¡¼­ ¼­¼­È÷ ¿ëÇØµÇ´Â »ýüÈí¼ö¼º ½ºÅÙÆ®´Â ¿µ±¸ÀûÀÎ ÀÓÇöõÆ®¸¦ ´ëüÇÒ ¼ö ÀÖ´Â À¯¸ÁÇÑ ´ë¾ÈÀ¸·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù. ·Îº¿À» ÀÌ¿ëÇÑ ½ºÅÙÆ® »ðÀÔ°ú AI¸¦ Ȱ¿ëÇÑ ¿µ»ó󸮷Π½ºÅÙÆ® »ðÀÔÀÇ Á¤È®µµ°¡ Çâ»óµÇ¾î ÀÓ»ó ¼º°ø·üÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù.

ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ® ¼ö¿ä¸¦ ÁÖµµÇÏ´Â ÇコÄÉ¾î ºÐ¾ß´Â?

ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ®´Â Ç÷°ü¼ºÇü¼ú¿¡ ³Î¸® »ç¿ëµÇ±â ¶§¹®¿¡ º´¿ø°ú ½ÉÀå Ä«Å×ÅÍ °Ë»ç½ÇÀº ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ®ÀÇ ÁÖ¿ä ÃÖÁ¾»ç¿ëÀÚÀÔ´Ï´Ù. ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASC)µµ ¿Ü·¡ ¼øÈ¯±â Ä¡·á·ÎÀÇ Àüȯ¿¡ µû¶ó ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ®ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Ç÷°ü ÁúȯÀÇ À§ÇèÀÌ ³ôÀº °í·É Àα¸´Â ½ºÅÙÆ®¸¦ ÀÌ¿ëÇÑ Ä¡·á ¼ö¿ä È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï ½ÃÀå¿¡¼­ÀÇ º¸Çè±Þ¿© Á¤Ã¥ ¹× ÀÇ·á ÀÎÇÁ¶óÀÇ ¹ßÀüÀº ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ® Ä¡·á¸¦ ´õ¿í Ä£¼÷ÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù.

ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ® ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ® ½ÃÀåÀÇ ¼ºÀåÀº ½ÉÇ÷°üÁúȯÀÇ À¯º´·ü Áõ°¡, ÃÖ¼Òħ½À ¼ö¼úÀÇ Ã¤Å÷ü Áõ°¡, ½ºÅÙÆ® Àç·á ¹× ¾à¹° ÄÚÆÃÀÇ Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å¿¡ ±âÀÎÇÕ´Ï´Ù. Â÷¼¼´ë ½ºÅÙÆ®¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ÀÇ·á Á¢±Ù¼º È®´ë´Â ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿¹¹æ½ÉÀåÇп¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡¿Í ¿µ»ó ±â¼úÀÇ ¹ßÀüÀ¸·Î ȯÀÚ ¼±º° ¹× Á¶±â °³ÀÔÀÌ °­È­µÇ°í ÀÖ½À´Ï´Ù. º¸´Ù ¾ÈÀüÇϰí È¿°úÀûÀÎ Ç÷°ü Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ® ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÀÌ·ê Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(°æµ¿¸Æ ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ®, ¼ÒÈ­°ü ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ®, Ç÷°ü³» ÀÚ°¡ È®ÀåÇü ½ºÅÙÆ®, ±âŸ), ¿ëµµ(´ëÅ𠵿¸Æ, Àå°ñµ¿¸Æ, °æµ¿¸Æ, ´ãµµ, ±âŸ), ÃÖÁ¾ ¿ëµµ(º´¿ø, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Self-Expanding Stents Market to Reach US$4.5 Billion by 2030

The global market for Self-Expanding Stents estimated at US$3.8 Billion in the year 2024, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Carotid Self-Expanding Stents, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Gastrointestinal Self-Expanding Stents segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$989.1 Million While China is Forecast to Grow at 3.0% CAGR

The Self-Expanding Stents market in the U.S. is estimated at US$989.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$728.5 Million by the year 2030 trailing a CAGR of 3.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Self-Expanding Stents Market - Key Trends & Drivers Summarized

Why Is The Demand For Self-Expanding Stents Growing In Cardiovascular And Peripheral Procedures?

Self-expanding stents have become a cornerstone in interventional cardiology and vascular procedures due to their ability to improve blood flow in patients with narrowed or blocked arteries. Unlike balloon-expandable stents, which require external pressure to open, self-expanding stents expand automatically upon deployment, offering greater flexibility and adaptability to vessel movement. The rising prevalence of cardiovascular diseases (CVDs), including coronary artery disease (CAD) and peripheral artery disease (PAD), is fueling the need for advanced stent technologies. Additionally, the increasing number of minimally invasive procedures is driving demand for self-expanding stents, as they reduce recovery time, lower complication risks, and improve long-term patient outcomes.

What Technological Innovations Are Enhancing The Effectiveness Of Self-Expanding Stents?

Advancements in biomaterials and drug-eluting coatings are significantly improving the performance and safety of self-expanding stents. Nitinol (nickel-titanium alloy) stents are becoming the preferred choice due to their superelasticity and resistance to deformation. Drug-eluting stents (DES), which release antiproliferative drugs, are reducing the risk of restenosis (re-narrowing of arteries), ensuring long-term patency. Additionally, bioresorbable stents, which gradually dissolve in the body after healing the artery, are emerging as a promising alternative to permanent implants. Robotic-assisted stent placement and AI-powered imaging are enhancing precision in stent deployment, improving clinical success rates.

Which Healthcare Sectors Are Driving The Demand For Self-Expanding Stents?

Hospitals and cardiac catheterization labs are the primary end-users of self-expanding stents, as they are widely used in angioplasty procedures. Ambulatory surgical centers (ASCs) are also witnessing increased adoption of self-expanding stents due to the shift toward outpatient cardiovascular interventions. The geriatric population, which is at higher risk for vascular diseases, is contributing to the growing demand for stent-based treatments. Additionally, advancements in reimbursement policies and healthcare infrastructure in emerging markets are making self-expanding stent procedures more accessible.

What Factors Are Fueling The Growth Of The Self-Expanding Stents Market?

The growth in the self-expanding stents market is driven by the increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive procedures, and continuous innovation in stent materials and drug coatings. Regulatory approvals for next-generation stents and expanded healthcare access in developing regions are further boosting market expansion. Additionally, growing awareness of preventive cardiology and advancements in imaging technologies are enhancing patient screening and early intervention. As the demand for safer and more effective vascular treatments continues to rise, the self-expanding stents market is poised for sustained growth.

SCOPE OF STUDY:

The report analyzes the Self-Expanding Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Carotid Self-Expanding Stents, Gastrointestinal Self-Expanding Stents, Endovascular Self-Expandable Stents, Others); Application (Fem-Pop Artery, Iliac Artery, Carotid Artery, Biliary, Others); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â